Association of CYP2C9*2 with bosentan-induced liver injury.
Markova SM; De Marco T; Bendjilali N; Kobashigawa EA; Mefford J; Sodhi J; Le H; Zhang C; Halladay J; Rettie AE; Khojasteh C; McGlothlin D; Wu AH; Hsueh WC; Witte JS; Schwartz JB; Kroetz DL; Clinical Pharmacology And Therapeutics, 2013, vol. 94, issue 6, p 678, ISSN 15326535. ISBN 15326535.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef